Literature DB >> 23073568

Prognostic indicators for long-term disability in multiple sclerosis patients.

Alfredo Damasceno1, Felipe Von Glehn, Carlos Otávio Brandão, Benito Pereira Damasceno, Fernando Cendes.   

Abstract

BACKGROUND: Daily practice is still faced with uncertainty in predicting the long-term disability of multiple sclerosis (MS). Most information comes from northern hemisphere cohorts, but in South America this information is scarce, and race, genetic and environmental factors could play an important role in the heterogeneity observed in disease outcomes.
METHODS: We evaluated 197 patients attending our MS Center gathering clinical and demographic information. Outcome measures analyzed were time from first clinical symptom to EDSS of 6, 7 and 8. For survival analysis we employed Cox regression models and the Kaplan-Meier method.
RESULTS: Time to EDSS 6 was 25.83 years (95% CI 15.36-36.31), and 36.25 years (95% CI 20.72-51.78) for EDSS 7. Male sex was associated with a 4.63 and 4.69 fold increased risk to EDSS 6 and 7, respectively (p<0.001 and p=0.006). Motor and brainstem symptoms at onset were also associated with an 8.1 and 13.1 fold increased risk to EDSS 6, respectively (p=0.04 and p=0.01). The number of relapses in five and ten years of disease onset was associated with a slightly increased risk to EDSS 8 (1.28 and 1.19, respectively; p=0.032 and p=0.015).
CONCLUSIONS: Male patients presenting with frequent relapses, especially those with motor and brainstem involvement, deserve close observation and should be cautiously monitored to early signs of treatment failure.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23073568     DOI: 10.1016/j.jns.2012.09.020

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  14 in total

Review 1.  Menopause in multiple sclerosis: therapeutic considerations.

Authors:  Riley Bove; Tanuja Chitnis; Maria Houtchens
Journal:  J Neurol       Date:  2013-10-08       Impact factor: 4.849

2.  Early predictive factors of disability in CIDP.

Authors:  Emanuele Spina; Antonietta Topa; Rosa Iodice; Stefano Tozza; Lucia Ruggiero; Raffaele Dubbioso; Marcello Esposito; Dario Bruzzese; Lucio Santoro; Fiore Manganelli
Journal:  J Neurol       Date:  2017-08-02       Impact factor: 4.849

3.  The impairment of the functional system and fatigue at the onset of the disease predict reaching disability milestones in relapsing-remitting multiple sclerosis differently in female and male patients.

Authors:  Alina Ivaniuk; Yuliia Solodovnikova; Tetiana Marusich; Anatoliy Son
Journal:  Acta Neurol Belg       Date:  2020-09-30       Impact factor: 2.396

Review 4.  Biological Sex As a Critical Variable in CD4+ Effector T Cell Function in Preclinical Models of Multiple Sclerosis.

Authors:  Muhammad Umair; Mohamed Reda Fazazi; Manu Rangachari
Journal:  Antioxid Redox Signal       Date:  2022-01-04       Impact factor: 7.468

5.  Relation between EDSS and monosymptomatic or polysymptomatic onset in clinical manifestations of multiple sclerosis in Babol, northern Iran.

Authors:  Seyed Mohammad Masood Hojjati; Seyyed Ali Hojjati; Mobina Baes; Ali Bijani
Journal:  Caspian J Intern Med       Date:  2014

Review 6.  Apparent changes in the epidemiology and severity of multiple sclerosis.

Authors:  Nils Koch-Henriksen; Melinda Magyari
Journal:  Nat Rev Neurol       Date:  2021-09-28       Impact factor: 42.937

7.  No sex-specific difference in disease trajectory in multiple sclerosis patients before and after age 50.

Authors:  Riley Bove; Alexander Musallam; Brian C Healy; Maria Houtchens; Bonnie I Glanz; Samia Khoury; Charles R Guttmann; Philip L De Jager; Tanuja Chitnis
Journal:  BMC Neurol       Date:  2013-07-03       Impact factor: 2.474

8.  Predictors of disability worsening in clinically isolated syndrome.

Authors:  Vilija G Jokubaitis; Tim Spelman; Tomas Kalincik; Guillermo Izquierdo; François Grand'Maison; Pierre Duquette; Marc Girard; Alessandra Lugaresi; Pierre Grammond; Raymond Hupperts; José Cabrera-Gomez; Celia Oreja-Guevara; Cavit Boz; Giorgio Giuliani; Ricardo Fernández-Bolaños; Gerardo Iuliano; Jeannette Lechner-Scott; Freek Verheul; Vincent van Pesch; Tatjana Petkovska-Boskova; Marcela Fiol; Fraser Moore; Edgardo Cristiano; Raed Alroughani; Roberto Bergamaschi; Michael Barnett; Mark Slee; Norbert Vella; Joseph Herbert; Cameron Shaw; Maria Laura Saladino; Maria Pia Amato; Danny Liew; Damiano Paolicelli; Helmut Butzkueven; Maria Trojano
Journal:  Ann Clin Transl Neurol       Date:  2015-03-27       Impact factor: 4.511

9.  Central Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional Study.

Authors:  Regina Maria Papais-Alvarenga; Claudia Cristina Ferreira Vasconcelos; Adriana Carra; Ibis Soto de Castillo; Sara Florentin; Fernando Hamuy Diaz de Bedoya; Raul Mandler; Luiza Campanella de Siervi; Maria Lúcia Vellutini Pimentel; Marina Papais Alvarenga; Marcos Papais Alvarenga; Anderson Kuntz Grzesiuk; Ana Beatriz Calmon Gama Pereira; Antonio Pereira Gomes Neto; Carolina Velasquez; Carlos Soublette; Cynthia Veronica Fleitas; Denise Sisteroli Diniz; Elizabeth Armas; Elizabeth Batista; Freda Hernandez; Fernanda Ferreira Chaves da Costa Pereira; Heloise Helena Siqueira; Hideraldo Cabeça; Jose Sanchez; Joseph Bruno Bidin Brooks; Marcus Vinicius Gonçalves; Maria Cristina Del Negro Barroso; Maria Elena Ravelo; Maria Carlota Castillo; Maria Lúcia Brito Ferreira; Maria Sheila Guimarães Rocha; Monica Koncke Fiuza Parolin; Omaira Molina; Patricia Beatriz Christino Marinho; Paulo Pereira Christo; Renata Brant de Souza; Silvio Pessanha Neto; Solange Maria das Graças Camargo; Suzana Costa Machado; Vanderson Carvalho Neri; Yara Dadalti Fragoso; Helcio Alvarenga; Luiz Claudio Santos Thuler
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

Review 10.  Mindfulness based interventions in multiple sclerosis--a systematic review.

Authors:  Robert Simpson; Jo Booth; Maggie Lawrence; Sharon Byrne; Frances Mair; Stewart Mercer
Journal:  BMC Neurol       Date:  2014-01-17       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.